Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode BFRI GELS PRPH AYTU EVGN DWTX SNSE TRIB COCP IMNN
6M 15.33 % -54.69 % -82.43 % 17.67 % -22.79 % -8.75 % 7.56 % -70.86 % -35.91 % -73.60 %
YTD -33.94 % -63.45 % -93.01 % 48.82 % -45.88 % 74.50 % -11.55 % -78.53 % -58.01 % -78.98 %
1Y -32.71 % -64.63 % -90.24 % 65.36 % -37.87 % 67.18 % 0.33 % -75.36 % -60.72 % -72.07 %
3Y -95.76 % -70.41 % -98.71 % -33.42 % -84.44 % -26.14 % -66.51 % -95.88 % -45.28 % -83.16 %
5Y -99.18 % -70.41 % -98.84 % -97.96 % -98.13 % -97.87 % -97.59 % -99.01 % -94.52 % -98.04 %
10Y -99.18 % -70.41 % -98.00 % -100.00 % -98.84 % -98.95 % -97.59 % -99.66 % -99.50 % -99.95 %
From the beginning -99.18 % -70.41 % -75.40 % -100.00 % -92.22 % -98.95 % -97.59 % -99.75 % -99.89 % -100.00 %

Dividend

ProPhase Labs, Inc.

Trinity Biotech plc